Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-03-08
2011-03-08
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S009100, C424S009200, C424S184100, C424S190100, C424S192100, C424S193100, C424S234100, C424S236100, C424S245100, C530S300000, C530S350000
Reexamination Certificate
active
07901689
ABSTRACT:
The invention provides a chimeric peptide or mixture of chimeric peptides that can be formulated as an immunizing composition and used in a method for immunization of a mammal against an internal peptide cleavage product derived from a precursor or mature protein, for which the peptide cleavage product and the precursor or mature protein are self molecules. The chimeric peptide or peptides have an end-specific B cell epitope from a naturally-occurring internal peptide cleavage product of a precursor or mature protein, as a free N- or C-terminus, fused with or without spacer residues to a T helper cell epitope derived from a living source different from that of the internal peptide cleavage product.
REFERENCES:
patent: 5879909 (1999-03-01), Perl
patent: WO98/23635 (1998-06-01), None
patent: 98/44955 (1998-10-01), None
patent: WO 99/27944 (1999-06-01), None
patent: WO-00/72876 (2000-12-01), None
patent: WO 00/72880 (2000-12-01), None
Schenk et al., “Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse”, Nature, 400.173 177 (Jul. 1999).
Sharma et al., “Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens”, Vaccine, 11:1321-1326 (1993).
Ifversen et al., “Induction of primary antigen-specific immune responses in SCID-hu-PBL by coupled T-B epitopes”, Immunology, 84:111-116 (1995).
O'Hern et al., “Colinear synthesis of an antigen-specific B-cell epitope with a ‘promiscuous’ tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive”, Vaccine, 16:1761-1766 (1997).
Ho et al., “Identification of two promiscuous T cell epitopes from tetanus toxin”, Eur. J. Immunol., 20:477-483 (1990).
Panina-Bordignon et al., “University immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells”, Eur. J. Immunol., 19:2237-2242 (1989).
Valmori et al., “Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination”, The Journal of Immunology, 149:717-721 (Jul. 15, 1992).
Valmori et al., “Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles”, Journal of Immunology, 2921-2929 (1994).
Schofield et al., “Sequences of the mouse F protein alleles and identification of a T cell epitope”, Eur. J. Immunol., 21:1235-1240 (1991).
Talwar et al. , “The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine”, American Journal of Reproductive Immunology, 37:153-160 (1997).
Iwatsubo et al., “Short communication full-length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques”, American Journal of Pathology, 149:1823-1830 (Dec. 1996).
Brons et al, “Hierarchic T-Cell Help to Non-Linked B-Cell Epitopes”,Scand J Immunol44:478-484 (1996).
Delmas et al, “The binding of chimeric peptides to GM1 ganglioside enables induction of antibody responses after intranasal immunization”Vaccine14(11):1077-1082 (1996).
Frenkel et al, “N-terminal EFRH sequence of Alzheimer's β-amylold peptide represents the epitope of its anti-aggreating antibodies”,J Neuroimmunology88:85-90 (1998).
Partidos et al, “The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides”,Eur J Immunol22:2675-2680 (1992).
Saido et al., “Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain,”Neurosience Letters 215:173-176 (1996).
Fish & Richardson P.C.
Intellect Neurosciences Inc.
Swartz Rodney P.
LandOfFree
Chimeric peptides as immunogens, antibodies thereto, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric peptides as immunogens, antibodies thereto, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric peptides as immunogens, antibodies thereto, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626853